246 related articles for article (PubMed ID: 9155117)
41. Detrusor instability as an energy-saving device in prostatic obstruction.
Cucchi A; Achilli MP; Ravasi S; Arrigoni N
J Urol; 1997 Mar; 157(3):866-70. PubMed ID: 9072588
[TBL] [Abstract][Full Text] [Related]
42. Correlation between prostatic urethral angle and bladder outlet obstruction index in patients with lower urinary tract symptoms.
Ku JH; Ko DW; Cho JY; Oh SJ
Urology; 2010 Jun; 75(6):1467-71. PubMed ID: 19962734
[TBL] [Abstract][Full Text] [Related]
43. Detrusor instability with equivocal obstruction: A predictor of unfavorable symptomatic outcomes after transurethral prostatectomy.
Machino R; Kakizaki H; Ameda K; Shibata T; Tanaka H; Matsuura S; Koyanagi T
Neurourol Urodyn; 2002; 21(5):444-9. PubMed ID: 12232878
[TBL] [Abstract][Full Text] [Related]
44. Implications of abdominal straining in women with lower urinary tract symptoms.
Yang JM; Huang WC
Urology; 2002 Sep; 60(3):428-33. PubMed ID: 12350479
[TBL] [Abstract][Full Text] [Related]
45. Opening contraction energy in prostatic (compressive) obstruction.
Cucchi A; van Mastrigt R
Urol Int; 1990; 45(1):16-9. PubMed ID: 1689521
[TBL] [Abstract][Full Text] [Related]
46. Efficacy of silodosin for relieving benign prostatic obstruction: prospective pressure flow study.
Matsukawa Y; Gotoh M; Komatsu T; Funahashi Y; Sassa N; Hattori R
J Urol; 2013 Jan; 189(1 Suppl):S117-21. PubMed ID: 23234615
[TBL] [Abstract][Full Text] [Related]
47. [Functional outcome after laser vaporisation of the prostate with the KTP laser].
Hamann MF; Wild C; Seif C; Hautmann S; Jünemann KP; Braun PM
Urologe A; 2007 May; 46(5):521-4, 526-7. PubMed ID: 17372716
[TBL] [Abstract][Full Text] [Related]
48. Is there a clinically significant change in pressure-flow study values after urethral instrumentation in patients with lower urinary tract symptoms?
Walker RM; Patel A; St Clair Carter S
Br J Urol; 1998 Feb; 81(2):206-10. PubMed ID: 9488059
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of flow electromyography in patients with benign prostatic hyperplasia.
Kitada S; Sakamoto N; Eto M; Koto S; Sakuma S; Takei M; Yamashita H; Osada Y; Kumazawa J
Urol Int; 1990; 45(3):148-52. PubMed ID: 1693454
[TBL] [Abstract][Full Text] [Related]
50. Predictive value of low maximum flow rate in benign prostatic hyperplasia.
Dorflinger T; Bruskewitz R; Jensen KM; Iversen P; Madsen PO
Urology; 1986 Jun; 27(6):569-73. PubMed ID: 2424165
[TBL] [Abstract][Full Text] [Related]
51. Detrusor contraction duration and strength in the patients with benign prostatic enlargement.
Aganović D; Prcić A
Bosn J Basic Med Sci; 2004 Feb; 4(1):29-33. PubMed ID: 15628977
[TBL] [Abstract][Full Text] [Related]
52. Urodynamic findings in boys with posterior urethral valves after treatment with primary valve ablation or vesicostomy and delayed ablation.
Podestá ML; Ruarte A; Gargiulo C; Medel R; Castera R
J Urol; 2000 Jul; 164(1):139-44. PubMed ID: 10840447
[TBL] [Abstract][Full Text] [Related]
53. Transurethral needle ablation of the prostate: a urodynamic based study with 2-year followup.
Steele GS; Sleep DJ
J Urol; 1997 Nov; 158(5):1834-8. PubMed ID: 9334612
[TBL] [Abstract][Full Text] [Related]
54. Obstruction following anti-incontinence procedures: diagnosis and treatment with transvaginal urethrolysis.
Nitti VW; Raz S
J Urol; 1994 Jul; 152(1):93-8. PubMed ID: 8201698
[TBL] [Abstract][Full Text] [Related]
55. Test-retest variation of pressure flow parameters in men with bladder outlet obstruction.
Eri LM; Wessel N; Berge V
J Urol; 2001 Apr; 165(4):1188-92. PubMed ID: 11257668
[TBL] [Abstract][Full Text] [Related]
56. Effects of photoselective vaporization of the prostate on urodynamics in patients with benign prostatic hyperplasia.
Seki N; Nomura H; Yamaguchi A; Naito S
J Urol; 2008 Sep; 180(3):1024-8; discussion 1028-9. PubMed ID: 18639299
[TBL] [Abstract][Full Text] [Related]
57. Data from frequency-volume charts versus maximum free flow rate, residual volume, and voiding cystometric estimated urethral obstruction grade and detrusor contractility grade in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
Van Venrooij GE; Eckhardt MD; Boon TA
Neurourol Urodyn; 2002; 21(5):450-6. PubMed ID: 12232879
[TBL] [Abstract][Full Text] [Related]
58. [Urodynamic evaluation of alpha-1 blocker tamsulosin on benign prostatic hyperplasia using pressure-flow study].
Miyatake R; Park YC; Koike H; Ohnishi N; Sugiyama T; Kurita T; Esa A; Kiwamoto H
Nihon Hinyokika Gakkai Zasshi; 1996 Aug; 87(8):1048-55. PubMed ID: 8831212
[TBL] [Abstract][Full Text] [Related]
59. Comparative study of pressure-flow parameters.
Eri LM; Wessel N; Tysland O; Berge V
Neurourol Urodyn; 2002; 21(3):186-93. PubMed ID: 11948710
[TBL] [Abstract][Full Text] [Related]
60. [Clinical evaluation of isometric detrusor pressure in patients with benign prostatic hyperplasia].
Nishimoto K
Hinyokika Kiyo; 1990 Jan; 36(1):19-26. PubMed ID: 1689929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
